newsfilter
← Latest News
Business Wire·

Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates

Actively enrolling patients with lupus nephritis (LN), systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) in Phase 1 clinical trial of ADI-001 in autoimmune diseases On track to report preliminary